Month: November 2020

The Federal Aviation Administration said it supported the “first mass air shipment” of Covid-19 vaccines on Friday, as pharmaceutical companies and airlines prepare networks for broad distribution. United Airlines carried Pfizer‘s Covid-19 vaccine from Brussels to Chicago O’Hare International Airport, according to people familiar with the matter. Ahead of the approvals, pharmaceutical companies, airlines and
0 Comments
Special message from Dr Tereza Kasaeva, Director of WHO’s Global TB Programme on the occasion of World Children’s Day and World Antimicrobial Awareness Week World Children’s Day marks the day, over three decades ago, on which world leaders adopted the historic Convention of the Rights of the Child, promising to every child to promote and
0 Comments
Response coordinator for White House Coronavirus Task Force Deborah Birx speaks as President Donald Trump listens during the daily briefing on the novel coronavirus, COVID-19, in the Brady Briefing Room of the White House in Washington, DC on April 21, 2020. Mandel Ngan | AFP | Getty Images WASHINGTON — White House coronavirus response coordinator Dr. Deborah
0 Comments
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, wears a protective mask during a news conference in the White House in Washington, D.C., U.S., on Thursday, Nov. 19, 2020. Chris Kleponis | Bloomberg | Getty Images Dr. Anthony Fauci, the nation’s top infectious disease expert, said on Sunday that the U.S.
0 Comments
Researchers duo Emma Derbyshire and Joanne Delange from the Nutritional Insight, Surrey, United Kingdom, explore the role of immunonutrition – nutrition that boosts or influences the immune system for those over 65 years of age in COVID-19. Their study titled, “COVID-19: is there a role for immunonutrition, particularly in the over 65s?,” was released in
0 Comments
Traders work the floor of the New York Stock Exchange. NYSE LONDON — Deutsche Bank upgraded its global growth outlook for 2021 but cautioned that two key risks could still spoil the economic recovery from the coronavirus crisis. In the bank’s latest report out Wednesday — entitled “Hope on the horizon” — Deutsche Bank researchers
0 Comments
Nov 27 2020 A Monash University project will look at reducing the long-term risk of adolescent mental health problems by enhancing parents’ ability to support their children throughout the pandemic. A digital mental health project led by researchers from the Faculty of Medicine, Nursing and Health Sciences and the Faculty of Information Technology, received a
0 Comments
A recent study published in the journal Phytotherapy Research reveals that resveratrol, a phenolic compound produced by spermatophytes, can inhibit the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), in in vitro setups. As of November 26, 2020, more than 61.1 million confirmed cases of COVID-19,
0 Comments
A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Dado Ruvic | Reuters More data will be needed from AstraZeneca‘s coronavirus vaccine trials to determine the drug’s safety and efficacy following concerns from experts in the U.S., scientists from the University of Oxford and the
0 Comments
Decreases in hospital attendances and admissions amid fears of COVID-19 may result in avoidable harm for under 16s say researchers, who warn against the “unintended consequences of pandemic control measures”. Research led by Dr Rachel Isba from Lancaster University, Dr Rachel Jenner from Royal Manchester Children’s Hospital, and Dr Marc Auerbach from Yale University analyzed
0 Comments
Arcturus Therapeutics is co-developing a vaccine candidate for Covid-19 in collaboration with Duke-NUS Medical School in Singapore, called ARCT-021. Jakub Porzycki | NurPhoto | Getty Images SINGAPORE — A Covid-19 vaccine candidate co-developed by Singapore scientists has shown positive interim results and could be available as early as 2021. That’s according to American biopharmaceutical firm
0 Comments
Results of a new study show that opioid overdose deaths involving more than one substance (polysubstances) are more common than opioid-only overdose deaths among youth. Led by researchers at Boston Medical Center’s Grayken Center for Addiction, the data shows that cocaine and other stimulants like crystal methamphetamine are the substances most commonly involved in opioid
0 Comments
The time of implementation and relaxation of non-pharmaceutical interventions (NPIs) such as border closures, national lockdowns, quarantines, and social distancing protocols during the COVID-19 pandemic has been a polarising topic of debate globally. Decision-makers are having a tough time grasping how best to balance the surge in infections and the socio-economic costs of sustaining NPIs
0 Comments
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumors, has shown promising early results in children with neuroblastoma, a rare form of childhood cancer. For this proof-of-principle study, researchers at the UCL Great Ormond Street Institute for Child Health (GOS ICH) and the UCL Cancer Institute modified the
0 Comments
Research indicates that starting school later in the morning yields health and academic benefits for high schoolers, whose natural body clock tends toward late-to-bed, late-to-rise habits. While parents raise concerns about drowsy driving, irritation and impaired school performance, a new study led by researchers at UC San Francisco suggests another reason to push back the
0 Comments
In a recent cutting-edge study, US researchers unveiled an anti-staphylococcal enterotoxin B monoclonal antibody that can be repurposed to target the cleavage site of the SARS-CoV-2 spike glycoprotein and, in turn, inhibit viral infection. Their findings are currently available on bioRxiv* preprint server. SARS-CoV-2, a causative agent of coronavirus disease (COVID-19), can give rise to
0 Comments